Listed

Fortress Biotech, Inc.

FBIONasdaqCIK 1429260HealthcareFiscal year ends Dec 31

Reports and events: 360 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Fortress Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2020-06-1917:01 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-20-075304
2020-05-2917:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-067844
2020-05-2817:07 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-067133
2020-05-1116:49 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-059608
2020-05-1116:38 ET10-QQuarterly reportPeriod 2020-03-310001104659-20-059592
2020-04-2716:33 ETDEF 14AProxy statementPeriod 2020-06-170001104659-20-051629
2020-03-2309:25 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-037129
2020-03-1617:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-20-034151
2020-03-1616:53 ET10-KAnnual reportPeriod 2019-12-310001104659-20-034133
2020-02-1217:21 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-20-019375
2019-12-3116:01 ET8-K5.02 Departure or appointment of officers or directors0001104659-19-077300
2019-11-2617:26 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-19-067710
2019-11-1207:41 ET10-QQuarterly reportPeriod 2019-09-300001104659-19-062059
2019-11-1207:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-19-062049
2019-08-1908:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001144204-19-040500
2019-08-0916:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-19-038918
2019-08-0916:04 ET10-QQuarterly reportPeriod 2019-06-300001144204-19-038876
2019-06-2016:38 ET8-K5.07 Shareholder vote results0001144204-19-031733
2019-05-1717:06 ETSC 13D/AOwnership report, active investor, amended0001144204-19-027112
2019-05-1016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-19-025266
2019-05-1016:03 ET10-QQuarterly reportPeriod 2019-03-310001144204-19-025261
2019-04-3007:24 ETDEF 14AProxy statementPeriod 2019-06-180001144204-19-022105
2019-04-1916:19 ETSC 13D/AOwnership report, active investor, amended0001144204-19-020408
2019-04-1916:18 ETSC 13D/AOwnership report, active investor, amended0001144204-19-020407
2019-04-1916:18 ETSC 13D/AOwnership report, active investor, amended0001144204-19-020405
2019-03-1817:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-19-014679
2019-03-1816:09 ET10-KAnnual reportPeriod 2018-12-310001144204-19-014617
2019-02-1515:01 ET8-K2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-008647
2019-02-1108:52 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-19-005992
2019-01-3107:52 ET8-K1.01 Entry into a material agreement0001144204-19-003899
2018-11-2616:15 ETSC 13D/AOwnership report, active investor, amended0001144204-18-061520
2018-11-2015:06 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-061024
2018-11-1611:27 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001144204-18-060419
2018-11-0908:40 ET10-QQuarterly reportPeriod 2018-09-300001144204-18-058518
2018-11-0907:35 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-058503
2018-08-0916:17 ET10-QQuarterly reportPeriod 2018-06-300001144204-18-043295
2018-08-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-043288
2018-06-1916:15 ET8-K5.07 Shareholder vote results0001144204-18-034794
2018-05-1016:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-027165
2018-05-1016:29 ET10-QQuarterly reportPeriod 2018-03-310001144204-18-027157
2018-04-3016:52 ETDEF 14AProxy statementPeriod 2018-06-140001571049-18-000271
2018-04-0517:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-18-019426
2018-03-1616:29 ET10-KAnnual reportPeriod 2017-12-310001144204-18-015301
2018-03-1608:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-18-015102
2017-12-1407:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001144204-17-063589
2017-11-0916:47 ET10-QQuarterly reportPeriod 2017-09-300001144204-17-057789
2017-11-0916:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001144204-17-057742
2017-11-0717:20 ET8-K1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001144204-17-056956
2017-10-1908:59 ETSC 13DOwnership report, active investor0001144204-17-053129
2017-08-0916:43 ET10-QQuarterly reportPeriod 2017-06-300001144204-17-041727

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:27 ET. Listed shows no prices and gives no investment advice.